Glanbia Nutritionals introduces creatine monohydrate with higher solubility and stability
Glanbia Nutritionals has launched a new creatine monohydrate ingredient called CreaBev that the company says is more soluble and stable than other creatine monohydrate ingredients on the market.
Photo © iStockphoto.com/Starcevic
Glanbia Nutritionals (Chicago, IL) has launched a new creatine monohydrate ingredient called CreaBev with a patent-pending encapsulation technology the company says makes it more soluble and stable than other creatine monohydrate ingredients on the market. In a short-term study conducted by the company, 98% of CreaBev’s creatine monohydrate remained present in water after two hours compared to standard creatine monohydrate, 11% of which degraded after only five minutes to the waste product creatinine.
In a long-term study, following exposure to the high processing temperatures of Ultra Heat Treatment (UHT), 70% of CreaBev’s creatine monohydrate remained after 12 months, while 95% of standard creatine monohydrate degraded after just three months. Additionally, CreaBev did not experience crystallization or clumping following UHT.
“Creatine has been a widely utilized ingredient for years and there is sufficient consumer knowledge on its benefits of use,” says Mayuresh Bedekar, senior product manager, Bioactives, for Glanbia, in a press release. “However, now manufacturers of pre- and post-workout products will have access to a more efficient form of creatine monohydrate that opens up new beverage product formulation possibilities.”
Kratom sees impressive sales growth despite its regulatory status and stigma
March 12th 2025Despite its controversy, kratom is a top-selling ingredient that consumers see value in. That said, brands need to work hard to demonstrate safety and quality of kratom products in the absence of legal regulatory status. Will kratom be able to overcome its stigma for even more growth and consumer acceptance?
DOJ asks Utah court to dismiss FTC lawsuit against Xlear Inc.
March 11th 2025On March 10, the DOJ and the defendant filed a stipulation to dismiss with prejudice the lawsuit in which each party agrees “to be responsible for its own costs and fees and agrees that no party shall be responsible to any other party for any fines, costs, fees, or penalties arising from this case.”
